Quantification of the cells in the gray matter yielded a significant group difference with 17,792 ± 936 caspase-3-positive cells/mm3 in the NPC group vs. 22,366 ± 1,088 in the control group (p < 0.01; Figure 7C). The gene discussed is CASP3; the disease is nasopharyngeal carcinoma.